Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer greater benefits than just weight and diabetes management.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.

Many people use semaglutides like Ozempic for weight loss, but can you use it to lose a small amount—say, 10 or 20 pounds? Doctors explain the concerns.

A recent study revealed that weight loss medications like Ozempic and Mounjaro might help individuals battling addiction. The findings, published in the scientific journal Addiction, said that people with alcohol addiction who were prescribed these medications had a 50 per cent lower rate of binge drinking compared to those who were not.